HMC(HMC)
HMC
Q4 2026 EPS Estimate
$0.29
Nov 6, 2026 · Reports before open
Revenue Estimate
$36.31B
FY2027E EPS$424.45
FY2028E EPS$653.53
Analyst Sentiment
Wall St. Consensus
Hold18 analysts·Moderate coverage
56
Score
5 Buy (28%)12 Hold (67%)1 Sell (5%)
Rating Breakdown
Strong Buy
00%
Buy
528%
Hold
1267%
Sell
16%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$31.51
+0.6%
Consensus
$31.51
+0.6%
Bull
$31.51
+0.6%
12-Month Target Range18 analysts
$31.51$31.51$31.51
Current $31.33Consensus
Current Price
$31.33
Upside to Consensus
$0.18
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+11.36%
EPS—
FY2028
Rev+2.83%
EPS+53.97%
FY2029
Rev+2.78%
EPS+18.91%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $23.88T | $24.56T | $25.24T | $26.29T | $26.29T |
| Low | $22.77T | $23.41T | $24.06T | $25.06T | $25.06T |
| High | $25.34T | $26.06T | $26.79T | $27.90T | $27.90T |
| EBITDA Avg | $2.22T | $2.28T | $2.34T | $2.44T | $2.44T |
| Low | $2.11T | $2.17T | $2.23T | $2.32T | $2.32T |
| High | $2.35T | $2.42T | $2.48T | $2.59T | $2.59T |
| EBIT Avg | $1.18T | $1.21T | $1.24T | $1.30T | $1.30T |
| Low | $1.12T | $1.15T | $1.19T | $1.24T | $1.23T |
| High | $1.25T | $1.28T | $1.32T | $1.37T | $1.37T |
| Net Income Avg | $565.53B | $870.76B | $1.04T | $1.19T | $1.14T |
| Low | $335.70B | $650.62B | $972.40B | $1.12T | $1.07T |
| High | $751.46B | $1.07T | $1.12T | $1.28T | $1.23T |
| EPS Avg | $424.45 | $653.53 | $777.08 | $892.19 | $855.47 |
| Low | $251.95 | $488.31 | $729.82 | $837.92 | $803.43 |
| High | $563.99 | $804.06 | $838.90 | $963.17 | $923.52 |
| Analysts (Rev / EPS) | 7 / 2 | 9 / 2 | 4 / 1 | 4 / 1 | 3 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.86T | $5.97T | $6.24T | $6.06T | $6.21T | $6.22T | $6.36T | $6.25T |
| Low | $5.52T | $5.76T | $5.95T | $5.78T | $5.92T | $5.93T | $6.06T | $5.96T |
| High | $6.27T | $6.21T | $6.58T | $6.40T | $6.56T | $6.56T | $6.71T | $6.60T |
| EBITDA Avg | $543.73B | $553.29B | $578.54B | $562.28B | $576.04B | $576.83B | $589.83B | $579.86B |
| Low | $512.11B | $534.19B | $551.73B | $536.23B | $549.34B | $550.10B | $562.50B | $552.99B |
| High | $581.46B | $576.30B | $610.63B | $593.48B | $608.00B | $608.84B | $622.55B | $612.03B |
| EBIT Avg | $288.94B | $294.02B | $307.43B | $298.79B | $306.10B | $306.53B | $313.43B | $308.13B |
| Low | $272.13B | $283.87B | $293.19B | $284.95B | $291.92B | $292.32B | $298.91B | $293.86B |
| High | $308.99B | $306.24B | $324.49B | $315.37B | $323.09B | $323.53B | $330.82B | $325.23B |
| Net Income Avg | $64.57B | $48.16B | $24.09B | $321.65B | $254.60B | $203.14B | $89.25B | $345.26B |
| Low | $60.68B | $45.26B | $22.64B | $302.27B | $239.26B | $190.90B | $83.87B | $324.46B |
| High | $69.22B | $51.63B | $25.83B | $344.85B | $272.96B | $217.79B | $95.68B | $370.16B |
| EPS Avg | $46.09 | $34.38 | $17.20 | $229.63 | $181.76 | $145.02 | $63.71 | $246.48 |
| Low | $43.32 | $32.31 | $16.16 | $215.79 | $170.81 | $136.28 | $59.88 | $231.63 |
| High | $49.42 | $36.86 | $18.44 | $246.19 | $194.87 | $155.48 | $68.31 | $264.26 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 6 / 1 | 5 / 1 | 4 / 1 |